Axim Biotechnologies Inc Revenue per Employee (AXIM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Axim Biotechnologies Inc   (AXIM)
 

Axim Biotechnologies Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 76.04% in the second quarter 2024, year on year to cumulative value of $0 million, Axim Biotechnologies Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,059, this is below the company average.
Within the Healthcare sector Employees of 560 other companies have achieved higher revenue per employee. While Axim Biotechnologies Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 3559. Axim Biotechnologies Inc has 45 employees.


What is Sales per Employee Ratio?







AXIM Revenue per Employee (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Revenue Change 76.04 % 616.22 % 66.79 % 629.15 % -
Sales per Employee (TTM) $ 2,059 1,891 878 766 582
AXIM's Total Ranking # 3559 # 0 # 0 # 0 # 0
Seq. Revenue Change -67.01 % 320.1 % 31.63 % -3.5 % 34.23 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 217
Healthcare Sector # 561
Overall Market # 3559

Revenue per Employee Statistics
High Average Low
$ 17,766 $ 3,744 $ 0
(Dec 31 2019)   (Sep 30 2021)



Financial Statements
Axim Biotechnologies Inc 's Revenue MRQ $ 0 Millions Visit AXIM's Income Statement
Axim Biotechnologies Inc 's Revenues TTM $ 0 Millions Visit AXIM's aggregate revenue growth
What are AXIM's Sales? Visit AXIM's Sales by Segment




Other Ratios
Axim Biotechnologies Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AXIM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AXIM's Competitors
Revenue per Employee for AXIM's Suppliers
Revenue per Employee for AXIM's Customers

You may also want to know
AXIM's Sales Growth Rates AXIM's Pe Price to earnings ratio AXIM's Receivables Turnover Ratio AXIM's Stock Quote
AXIM's Net Income Growth Rates AXIM's Ps Price to Sales ratio AXIM's Sales per Employee AXIM's Asset Turnover Ratio
AXIM's Net Margin AXIM's Pb Price to Book ratio AXIM's Financial Strength Ratios AXIM's Dividend Payout Ratio
Date modified: 2026-08-29T23:43:02+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2024Number of Employees Jun 30 2024
Hyperion Defi inc   3,489.44 $ 0.031  Million
Evaxion A  3,422.22 $ 0.154  Million 45 
Cardio Diagnostics Holdings Inc   2,302.24 $ 0.039  Million 17 
Axim Biotechnologies Inc   2,058.89 $ 0.093  Million 45 
Biocorrx Inc   2,041.56 $ 0.037  Million 18 
Immunitybio inc   1,892.91 $ 1.308  Million 691 
Opthea Limited  1,860.69 $ 0.125  Million 67 
Sol gel Technologies Ltd   1,552.29 $ 5.433  Million 3,500 
Viridian Therapeutics Inc   1,142.86 $ 0.288  Million 252 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.